# OnCo record majic-et (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/majic-et/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "majic-et" ;
  schema:name "MAJIC-ET"@en ;
  schema:description "MAJIC-ET found that ruxolitinib was no better than the usual second-line drugs at controlling platelets in ET, although it eased itching and other symptoms."@en ;
  schema:url <https://onco.cc/trials/majic-et/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://www.isrctn.com/ISRCTN61925716> ;
  onco:status "negative" ;
  onco:tag "essential-thrombocythaemia", "mpn" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/essential-thrombocythaemia/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/ruxolitinib/>, <https://onco.cc/drugs/anagrelide/> .